A Milestone Year
Anne L. Peters, MD: Hi. I'm Dr Anne Peters. I am at the European Association for the Study of Diabetes (EASD) meetings in Vienna. I am very honored today to be with two individuals whose work I have read for many years: Dr George Alberti and Dr Ele Ferrannini, who are both past presidents of the EASD. We are celebrating the 50th anniversary of the EASD, so we thought it would be a good time to discuss what has been going on in the organization. Let's start with history. Tell me how it began.
K. George M. Alberti, DPhil, FRCP: I will answer that, because I am much more "past" than Ele. The organization started 50 years ago in Montecatini. A very celebrated Swiss diabetologist, Albert Renold, had been head of the Joslin Clinic in the United States and had been to American Diabetes Association (ADA) meetings. He came back to Europe and thought we needed some sort of get-together for people interested in researching diabetes. They called the organization the "European Association for the Study of Diabetes," so it was research-oriented from the beginning, and it was a society of individuals, not nations. National associations and national politics did not come into it at all, and it has remained, very jealously, an individual membership society.
Type 2 Diabetes Mellitus
Type 2 Diabetes Mellitus Clinical Practice Guidelines (SID/AMD, 2022)
Pediatric Type 2 Diabetes Mellitus
COMMENTARY
EASD at 50: What's Driving the Future?
'The European Meeting' Focuses on Science, Young Researchers
Anne L. Peters, MD; K. George M. Alberti, DPhil, FRCP; Eleuterio Ferrannini, MD, PhD
DisclosuresSeptember 25, 2014
A Milestone Year
Anne L. Peters, MD: Hi. I'm Dr Anne Peters. I am at the European Association for the Study of Diabetes (EASD) meetings in Vienna. I am very honored today to be with two individuals whose work I have read for many years: Dr George Alberti and Dr Ele Ferrannini, who are both past presidents of the EASD. We are celebrating the 50th anniversary of the EASD, so we thought it would be a good time to discuss what has been going on in the organization. Let's start with history. Tell me how it began.
K. George M. Alberti, DPhil, FRCP: I will answer that, because I am much more "past" than Ele. The organization started 50 years ago in Montecatini. A very celebrated Swiss diabetologist, Albert Renold, had been head of the Joslin Clinic in the United States and had been to American Diabetes Association (ADA) meetings. He came back to Europe and thought we needed some sort of get-together for people interested in researching diabetes. They called the organization the "European Association for the Study of Diabetes," so it was research-oriented from the beginning, and it was a society of individuals, not nations. National associations and national politics did not come into it at all, and it has remained, very jealously, an individual membership society.
Medscape Diabetes © 2014 WebMD, LLC
Cite this: EASD at 50: What's Driving the Future? - Medscape - Sep 25, 2014.
Tables
Authors and Disclosures
Authors and Disclosures
Co-Authors
Anne L. Peters, MD, CDE
Professor of Clinical Medicine; Director, Clinical Diabetes Programs, Keck School of Medicine, University of Southern California, Los Angeles, California
Disclosure: Anne L. Peters, MD, has disclosed the following financial relationships:
Served as director, officer, partner, employee, advisor, consultant, or trustee for: (current consultant): Amylin Pharmaceuticals, Inc.; Eli Lilly and Company; Novo Nordisk.
Served as a speaker or member of a speakers bureau for: (current speakers bureau member): Amylin Pharmaceuticals, Inc.; Eli Lilly and Company; Novo Nordisk; Takeda Pharmaceuticals North America, Inc.
Served as a consultant or ad hoc speaker/consultant for: AstraZeneca Pharmaceuticals LP; Abbott Laboratories; Boehringer Ingelheim Pharmaceuticals, Inc.; Bristol-Myers Squibb Company; Dexcom; Medtronic MiniMed, Inc.; Merck & Co., Inc.; Roche; sanofi-aventis
K. George M. Alberti, DPhil, FRCP
Senior Research Investigator, Imperial College, London, United Kingdom
Disclosure: K. George M. Alberti, DPhil, FRCP, has disclosed the following relevant financial relationship:
Serve(d) as a director, officer, partner, employee, advisor, consultant, or trustee, for: Fractyl Laboratories Inc.
Eleuterio Ferrannini, MD, PhD
Professor of Medicine, University of Pisa, Pisa, Italy
Dislcosure: Ele Ferrannini, MD, has disclosed the following relevant financial relationships:
Serve(d) as a director, officer, partner, employee, advisor, consultant, or trustee for: Boehringer Ingelheim Pharmaceuticals, Inc.; Merck Sharp & Dohme Corp.; sanofi-aventis
Serve(d) as a speaker or a member of a speakers bureau for: Boehringer Ingelheim Pharmaceuticals, Inc.; Merck Sharp & Dohme Corp.; sanofi-aventis; Takeda
Received research grant from: Boehringer Ingelheim Pharmaceuticals, Inc.; Eli Lilly and Company